1. Home
  2. BCYC vs PKST Comparison

BCYC vs PKST Comparison

Compare BCYC & PKST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • PKST
  • Stock Information
  • Founded
  • BCYC 2009
  • PKST 2008
  • Country
  • BCYC United Kingdom
  • PKST United States
  • Employees
  • BCYC N/A
  • PKST N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • PKST Real Estate Investment Trusts
  • Sector
  • BCYC Health Care
  • PKST Real Estate
  • Exchange
  • BCYC Nasdaq
  • PKST Nasdaq
  • Market Cap
  • BCYC 529.8M
  • PKST 454.7M
  • IPO Year
  • BCYC 2019
  • PKST N/A
  • Fundamental
  • Price
  • BCYC $7.10
  • PKST $12.79
  • Analyst Decision
  • BCYC Buy
  • PKST Buy
  • Analyst Count
  • BCYC 12
  • PKST 2
  • Target Price
  • BCYC $22.91
  • PKST $16.00
  • AVG Volume (30 Days)
  • BCYC 261.8K
  • PKST 191.4K
  • Earning Date
  • BCYC 08-08-2025
  • PKST 08-07-2025
  • Dividend Yield
  • BCYC N/A
  • PKST 7.25%
  • EPS Growth
  • BCYC N/A
  • PKST N/A
  • EPS
  • BCYC N/A
  • PKST N/A
  • Revenue
  • BCYC $19,281,000.00
  • PKST $223,891,000.00
  • Revenue This Year
  • BCYC $7.35
  • PKST N/A
  • Revenue Next Year
  • BCYC N/A
  • PKST N/A
  • P/E Ratio
  • BCYC N/A
  • PKST N/A
  • Revenue Growth
  • BCYC N/A
  • PKST N/A
  • 52 Week Low
  • BCYC $6.10
  • PKST $10.14
  • 52 Week High
  • BCYC $28.67
  • PKST $16.26
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 37.11
  • PKST 47.28
  • Support Level
  • BCYC $7.25
  • PKST $11.56
  • Resistance Level
  • BCYC $7.68
  • PKST $12.73
  • Average True Range (ATR)
  • BCYC 0.42
  • PKST 0.50
  • MACD
  • BCYC -0.07
  • PKST -0.02
  • Stochastic Oscillator
  • BCYC 12.80
  • PKST 48.66

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

About PKST Peakstone Realty Trust

Peakstone Realty Trust is an internally managed, publicly registered real estate investment trust (REIT) that owns and operates predominately single-tenant industrial and office properties with creditworthy tenants and long-term leases. Peakstone's portfolio consists of newer vintage, and well-located real estate assets in majorly high-growth coastal and sunbelt markets. The company has two reportable segments: Industrial and Office. The Industrial segment consists of industrial outdoor storage properties which have a low building-to-land ratio, or low coverage, maximizing yard space for the display, movement, and storage of materials and equipment. The Office segment includes office, R&D and data center properties.

Share on Social Networks: